Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumin Hu

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Cell Death & Disease|April 22, 2025
Targeting oncogenic activation of FLT3/SREBP/FASN promotes the therapeutic effect of quizartinib involving disruption of mitochondrial phospholipidsFeng Yin, Jing Yang, Hao Luo, et al.
Journal of Medicinal Chemistry|July 1, 2021
Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against LymphomaYalin Tu, Yameng Sun, Shuang Qiao, et al.
Autophagy|August 24, 2010
The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagyYue Wei, Tapan Kadia, Weigang Tong, et al.
Cancer Communications (London, England)|October 17, 2022
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilizationRui Liu, Panpan Liu, Huichang Bi, et al.
Molecular Cancer|March 2, 2017
Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signalingJianwei Liao, Pan-Pan Liu, Guoxin Hou, et al.
Cancer Communications (London, England)|April 6, 2019
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysisXin You, Weiye Jiang, Wenhua Lu, et al.
Hybridoma (2005)|February 26, 2009
Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1alpha signalZhongqin Cheng, Shiyong Zhou, Xuefeng Wang, et al.
RSC Advances|May 11, 2022
Design, synthesis and biological evaluation of <i>N</i>-arylsulfonyl carbazoles as novel anticancer agentsXin You, Daqian Zhu, Wenhua Lu, et al.
Redox Biology|August 5, 2020
Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivoXiaoxia Liu, Yanyu Zhang, Wenhua Lu, et al.
Journal of Medicinal Chemistry|May 2, 2022
Design and Synthesis of Dual EZH2/BRD4 Inhibitors to Target Solid TumorsZhirong Guo, Yameng Sun, Liyun Liang, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Cell Death & Disease|April 22, 2025
Targeting oncogenic activation of FLT3/SREBP/FASN promotes the therapeutic effect of quizartinib involving disruption of mitochondrial phospholipidsFeng Yin, Jing Yang, Hao Luo, et al.
Journal of Medicinal Chemistry|July 1, 2021
Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against LymphomaYalin Tu, Yameng Sun, Shuang Qiao, et al.
Autophagy|August 24, 2010
The combination of a histone deacetylase inhibitor with the BH3-mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagyYue Wei, Tapan Kadia, Weigang Tong, et al.
Cancer Communications (London, England)|October 17, 2022
Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilizationRui Liu, Panpan Liu, Huichang Bi, et al.
Molecular Cancer|March 2, 2017
Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signalingJianwei Liao, Pan-Pan Liu, Guoxin Hou, et al.
Cancer Communications (London, England)|April 6, 2019
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysisXin You, Weiye Jiang, Wenhua Lu, et al.
Hybridoma (2005)|February 26, 2009
Characterization and application of two novel monoclonal antibodies against human CXCR4: cell proliferation and migration regulation for glioma cell line in vitro by CXCR4/SDF-1alpha signalZhongqin Cheng, Shiyong Zhou, Xuefeng Wang, et al.
RSC Advances|May 11, 2022
Design, synthesis and biological evaluation of <i>N</i>-arylsulfonyl carbazoles as novel anticancer agentsXin You, Daqian Zhu, Wenhua Lu, et al.
Redox Biology|August 5, 2020
Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivoXiaoxia Liu, Yanyu Zhang, Wenhua Lu, et al.
Journal of Medicinal Chemistry|May 2, 2022
Design and Synthesis of Dual EZH2/BRD4 Inhibitors to Target Solid TumorsZhirong Guo, Yameng Sun, Liyun Liang, et al.
Pageof 10